Vaccine development and trials in low and lower-middle income countries: Key issues, advances and future opportunities

References

• State of the world's vaccines and immunization. Geneva, Switzerland: World Health Organization; 2009
   Google Scholar
• Drain PK, Robine M, Holmes KK, Bassett IV. Trial watch: Global migration of clinical trials. Nat Rev Drug Discov. 2014; 13:166-7. https://doi.org/10.1038/nrd4260. PMID:24577390
   PubMed Web of Science ®Google Scholar
• Viergever RF, Li K. Trends in global clinical trial registration: An analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013. BMJ Open. 2015; 5:e008932. https://doi.org/10.1136/bmjopen-2015-008932. PMID:26408831
   PubMed Web of Science ®Google Scholar
• The Globalization of Clinical Trials: A Growing Challenge in Protecting Human Subjects. Silver Spring, MD: United States Food and Drug Administration; 2001
   Google Scholar
• Clinical trials submitted in marketing-authorisation applications to the European Medicines Agency. Overview of patient recruitment and the geographical location of investigator sites. Containing data from 2005 to 2011. London, UK: European Medicines Agency; 2013; 39
   Google Scholar
• Rts SCTP. Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: A phase 3 randomized, controlled trial in children and young infants at 11 African sites. PLoS Med. 2014; 11:e1001685. https://doi.org/10.1371/journal.pmed.1001685. PMID:25072396
   PubMed Web of Science ®Google Scholar
• Clemens J, Moorthy V. Implementation of RTS,S/AS01 malaria vaccine–The need for further evidence. N Engl J Med. 2016; 374:2596-7. https://doi.org/10.1056/NEJMe1606007. PMID:27355540
   PubMed Web of Science ®Google Scholar
• Leach A, Vekemans J, Lievens M, Ofori-Anyinam O, Cahill C, Owusu-Agyei S, Abdulla S, Macete E, Njuguna P, Savarese B, et al. Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa. Malar J 2011; 10:224. https://doi.org/10.1186/1475-2875-10-224. PMID:21816029
   PubMed Web of Science ®Google Scholar
• Higgs ES, Hayden FG, Chotpitayasunondh T, Whitworth J, Farrar J. The Southeast Asian Influenza Clinical Research Network: Development and challenges for a new multilateral research endeavor. Antiviral Res 2008; 78:64-8. https://doi.org/10.1016/j.antiviral.2007.10.008. PMID:18295355
   PubMed Web of Science ®Google Scholar
• Wertheim HF, Puthavathana P, Nghiem NM, van Doorn HR, Nguyen TV, Pham HV, Subekti D, Harun S, Malik S, Robinson J, et al. Laboratory capacity building in Asia for infectious disease research: Experiences from the South East Asia Infectious Disease Clinical Research Network (SEAICRN). PLoS Med 2010; 7:e1000231. https://doi.org/10.1371/journal.pmed.1000231. PMID:20386725
   PubMed Web of Science ®Google Scholar
• Kochhar S. Challenges and impact of conducting vaccine trials in Asia and Africa: New Technologies in Emerging Markets, October 16th-18th 2012; World Vaccine Congress, Lyon. Hum Vaccin Immunother. 2013; 9:924-7. https://doi.org/10.4161/hv.23405. PMID:23321645
   PubMed Web of Science ®Google Scholar
• Acosta CJ, Galindo CM, Ochiai RL, Danovaro-Holliday MC, Laure-Page A, Thiem VD, Jin Y, Khan MI, Sahito SM, Hamza HB, et al. Implementation of good clinical practice guidelines in vaccine trials in developing countries. Vaccine. 2007; 25:2852-7. https://doi.org/10.1016/j.vaccine.2006.09.079. PMID:17141380
   PubMed Web of Science ®Google Scholar
• Emanuel EJ, Wendler D, Killen J, Grady C. What makes clinical research in developing countries ethical? The benchmarks of ethical research. J Infect Dis. 2004; 189:930-7. https://doi.org/10.1086/381709. PMID:14976611
   PubMed Web of Science ®Google Scholar
• ICH. ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice, 1996; 53. https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdf
   Google Scholar
• Maiga D, Akanmori BD, Chocarro L. Regulatory oversight of clinical trials in Africa: Progress over the past 5 years. Vaccine. 2009; 27:7249-52. https://doi.org/10.1016/j.vaccine.2009.08.113. PMID:19748580
   PubMed Web of Science ®Google Scholar
• WHO. WHO Technical Report Series. 2004. http://www.who.int/biologicals/publications/trs/areas/vaccines/clinical_evaluation/035-101.pdf?ua=1)
   Google Scholar
• Nishioka S, Southern J, Dominguez R, Dellepiane N. Helping each other regulate clinical trials: A network of vaccine regulators from developing countries. Clinical Investigation. 2013; 3:113-7. https://doi.org/10.4155/cli.12.151
   Google Scholar
• Choccaro L. Workshop on Regulatory Procedures for Clinical Evaluation of Vaccines, Addis Ababa 21–23 September 2005. WHO, 2005:28. http://www.who.int/immunization_standards/vaccine_regulation/meeting_report_addis_sept05.pdf
   Google Scholar
• Kirigia JM, Wambebe C, Baba-Moussa A. Status of national research bioethics committees in the WHO African region. BMC Med Ethics 2005; 6:E10. https://doi.org/10.1186/1472-6939-6-10. PMID:16242014
   PubMedGoogle Scholar
• Motari M, Ota MO, Kirigia JM. Readiness of ethics review systems for a changing public health landscape in the WHO African Region. BMC Med Ethics 2015; 16:82. https://doi.org/10.1186/s12910-015-0078-9. PMID:26626131
   PubMed Web of Science ®Google Scholar
• ICH. Integrated Addendum to ICH E6 (R1): Guideline for Good Clinical Practice E6 (R2). 2016:59. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R2__Step_4.pdf
   Google Scholar
• World Health Organization. WHO guidelines on clinical evaluation of vaccines: Regulatory expectations. WHO technical report series 2017, no. 1004, annex 9. http://www.who.int/biologicals/expert_committee/WHO_TRS_1004_web_Annex_9.pdf?ua=1
   Google Scholar
• Bhan MK, Glass RI, Ella KM, Bhandari N, Boslego J, Greenberg HB, Mohan K, Curlin G, Rao TS. Team science and the creation of a novel rotavirus vaccine in India: A new framework for vaccine development. Lancet. 2014; 383:2180-3. https://doi.org/10.1016/S0140-6736(14)60191-4. PMID:24629993
   PubMed Web of Science ®Google Scholar
• Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, Goyal N, Kawade A, Kang G, Rathore SS, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: A randomised, double-blind, placebo-controlled trial. Lancet. 2014; 383:2136-43. https://doi.org/10.1016/S0140-6736(13)62630-6. PMID:24629994
   PubMed Web of Science ®Google Scholar
• Witty A. New strategies for innovation in global health: A pharmaceutical industry perspective. Health Aff (Millwood). 2011; 30:118-26. https://doi.org/10.1377/hlthaff.2010.0933. PMID:21209447
   PubMed Web of Science ®Google Scholar
• Francis DP, Du YP, Precioso AR. Global vaccine supply. The increasing role of manufacturers from middle income countries. Vaccine. 2014; 32:5259-65. https://doi.org/10.1016/j.vaccine.2014.07.069. PMID:25110294
   PubMed Web of Science ®Google Scholar
• Devasenapathy N, Singh K, Prabhakaran D. Conduct of clinical trials in developing countries: A perspective. Curr Opin Cardiol. 2009; 24:295-300. https://doi.org/10.1097/HCO.0b013e32832af21b. PMID:19444095
   PubMed Web of Science ®Google Scholar
• Yusuf S. Clinical research and trials in developing countries. Stat Med. 2002; 21:2859-67. https://doi.org/10.1002/sim.1290. PMID:12325102
   PubMed Web of Science ®Google Scholar
• Amarasinghe A, Black S, Bonhoeffer J, Carvalho SM, Dodoo A, Eskola J, Larson H, Shin S, Olsson S, Balakrishnan MR, et al. Effective vaccine safety systems in all countries: A challenge for more equitable access to immunization. Vaccine. 2013;31 Suppl 2:B108-14. https://doi.org/10.1016/j.vaccine.2012.10.119. PMID:23598471
   PubMed Web of Science ®Google Scholar
• Olsson S, Pal S, Dodoo A. Pharmacovigilance in resource-limited countries. Expert Rev Clin Pharmacol. 2015; 8:11. https://doi.org/10.1586/17512433.2015.1053391. PMID:26041035
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global vaccine safety blueprint vision and strategic goals questions to SAGE. 2011. http://www.who.int/immunization/sage/SAGE_November_2011_Eskola.pdf
   Google Scholar
• WHO. Global Advisory Committee on Vaccine Safety, 15–16 June 2016. WHO Weekly Epidemiologocal Record 2016; 91:341-8
   PubMedGoogle Scholar
• Ogutu BR, Baiden R, Diallo D, Smith PG, Binka FN. Sustainable development of a GCP-compliant clinical trials platform in Africa: The Malaria Clinical Trials Alliance perspective. Malaria Journal 2010; 9:103.
   PubMed Web of Science ®Google Scholar